CryoCell International Inc (NYSE MKT:CCEL) — Market Cap & Net Worth
Market Cap & Net Worth: CryoCell International Inc (CCEL)
CryoCell International Inc (NYSE MKT:CCEL) has a market capitalization of $27.39 Million ($27.39 Million) as of September 17, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #24180 globally and #5212 in its home market, demonstrating a -5.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CryoCell International Inc's stock price $3.46 by its total outstanding shares 8055150 (8.06 Million). Also see balance sheet size of CryoCell International Inc for a full breakdown of the balance sheet.
CryoCell International Inc Market Cap History: 2015 to 2026
CryoCell International Inc's market capitalization history from 2015 to 2026. Data shows growth from $21.98 Million to $27.87 Million (1.54% CAGR). Also see CCEL operating cash flow for how efficiently the company converts equity into cash flow.
CryoCell International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CryoCell International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CryoCell International Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.87x
CryoCell International Inc's market cap is 1.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
148.44x
CryoCell International Inc's market cap is 148.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $21.98 Million | $21.09 Million | $8.11 Million | 1.04x | 2.71x |
| 2016 | $31.32 Million | $23.13 Million | -$1.32 Million | 1.35x | N/A |
| 2017 | $66.42 Million | $25.38 Million | $2.32 Million | 2.62x | 28.69x |
| 2018 | $51.52 Million | $29.22 Million | -$854.82K | 1.76x | N/A |
| 2019 | $48.98 Million | $31.82 Million | $2.29 Million | 1.54x | 21.38x |
| 2020 | $52.89 Million | $31.15 Million | $3.62 Million | 1.70x | 14.59x |
| 2021 | $79.68 Million | $28.88 Million | $2.08 Million | 2.76x | 38.24x |
| 2022 | $33.10 Million | $30.34 Million | $2.77 Million | 1.09x | 11.94x |
| 2023 | $44.99 Million | $31.34 Million | -$9.52 Million | 1.44x | N/A |
| 2024 | $59.69 Million | $31.99 Million | $402.10K | 1.87x | 148.44x |
Competitor Companies of CCEL by Market Capitalization
Companies near CryoCell International Inc in the global market cap rankings as of September 17, 2026. Review CCEL tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to CryoCell International Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
CryoCell International Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, CryoCell International Inc's market cap moved from $21.98 Million to $ 27.87 Million, with a yearly change of 1.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $27.87 Million | +0.58% |
| 2025 | $27.71 Million | -53.58% |
| 2024 | $59.69 Million | +32.67% |
| 2023 | $44.99 Million | +35.93% |
| 2022 | $33.10 Million | -58.46% |
| 2021 | $79.68 Million | +50.65% |
| 2020 | $52.89 Million | +7.99% |
| 2019 | $48.98 Million | -4.93% |
| 2018 | $51.52 Million | -22.44% |
| 2017 | $66.42 Million | +112.06% |
| 2016 | $31.32 Million | +42.50% |
| 2015 | $21.98 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of CryoCell International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.39 Million USD |
| MoneyControl | $27.39 Million USD |
| MarketWatch | $27.39 Million USD |
| marketcap.company | $27.39 Million USD |
| Reuters | $27.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CryoCell International Inc
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manu… Read more